One Stop Shop for All Your Market Research Reports

Global Immuno-oncology Therapy Market Insights and Forecast to 2028

Immuno-oncology Therapy market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Immuno-oncology Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type Monoclonal Antibodies Immune Checkpoint Inhibitors Immune System Modulators Cancer Vaccines Segment by Application Hospitals Ambulatory Surgical Center Others By Company Amgen AstraZeneca Bristol-Myers Squibb Eli-Lilly Roche GlaxoSmithKline Janssen Biotech Merck Novartis Pfizer Sanofi Spectrum Pharmaceuticals Takeda BioNTech SE Allogene Therapeutics IMAB-I-Mab Biopharma Co., Ltd. Arcus Biosciences Gritstone Oncology Autolus Therapeutics Rubius Therapeutics By Region North America United States Canada Europe Germany France UK Italy Russia Nordic Countries Rest of Europe Asia-Pacific China Japan South Korea Southeast Asia India Australia Rest of Asia Latin America Mexico Brazil Rest of Latin America Middle East & Africa Turkey Saudi Arabia UAE Rest of MEA
1 Report Business Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Immuno-oncology Therapy Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 Monoclonal Antibodies 1.2.3 Immune Checkpoint Inhibitors 1.2.4 Immune System Modulators 1.2.5 Cancer Vaccines 1.3 Market by Application 1.3.1 Global Immuno-oncology Therapy
Inquiry Before Buying

Request Sample

Share This Report

Our Clients

Payment Mode
Single User US $ 4900
Multi User US $7350
Corporate User US $9800
About this Report
Report ID 399155
Category
  • Pharmaceuticals and Healthcare
Published on 02-May
Number of Pages 129
Publisher Name QY Research
Editor Rating
★★★★★
★★★★★
(41)